EFPIA issues statement on conclusion of EU-Mercosur Free Trade Agreement
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has issued a statement following the conclusion of the EU-Mercosur Free Trade Agreement. The Director General of EFPIA, Nathalie Moll, welcomed the agreement as a step towards strengthening trade relations and noted that it includes some progress for the innovative pharmaceutical sector, particularly through partial tariff reductions. However, EFPIA stated that the agreement falls short of the level of ambition needed to fully support innovation. It specified that EU free trade agreements should seek to include key provisions on intellectual property protection, including Regulatory Data Protection and Supplementary Protection Certificates, as well as meaningful access to public procurement.